Willis Towers Watson Public Limited Comp... (WTW)
El precio, las cifras principales y las últimas noticias, en un solo sitio.
Willis Towers Watson Public Limited Company (WTW): cotización, análisis y datos
| Precio de compra | 343.6 |
| Capitalización de mercado | 31.1B |
| Ingresos (TTM) | 10.1B |
| Beneficio neto (TTM) | 1.56B |
| 0.42 | |
| 16.16 | |
| 20.7 | |
| 14.61 | |
| P/B (TTM) | 4.05 |
| P/S (TTM) | 3.07 |
| Fecha de resultados | Oct 29, 2026 |
| Precio de venta | 346.73 |
| Volumen | 407,099 |
| Volumen medio (20D) | 606,698 |
| Abierto | 341.12 |
| Anterior Cerrar | 338.55 |
| Rango del día | 333.30 - 342.82 |
| Rango de 52 semanas | 240.61 - 352.79 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | $3.84 (1.13%) |
| Fecha ex dividendo | Sep 30, 2026 |
Acerca de WTW
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. The company operates through two segments: Health, Wealth & Career and Risk & Broking. It offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit programs, including medical, dental, disability, life, voluntary benefits, and other cover...
Desempeño financiero
En 2025, los ingresos de Willis Towers Watson Public Company fueron 9.71B, una disminución de -2.24% en comparación con 9.93B del año anterior. Las ganancias fueron 1.61B, una disminución de -1,737.76%.
Estados financierosSorpresa de resultados
- Ingresos de $2.47B falla las estimaciones por $0, con 9.07% Crecimiento interanual.
- EPS de 3.35 supera las estimaciones en 0.24, con 17.13% Crecimiento interanual.
Los analistas proyectan ingresos de ... Actualizar
2 semanas hace · Simply Wall St.
Willis Towers Watson (WTW) Could Be 13% Below Fair Value After Leadership ChangeWillis Towers Watson (WTW) recently appointed Jayne Bok as Head of Hong Kong and Macau, while she continues as Head of Investments, Asia. This leadership change gives investors fresh context for think...
2 semanas hace · 24/7 Wall St.
If You Followed Seth Klarman Into Vaxcyte in May, He Was Already Long GoneRetail investors who spotted Seth Klarman buying Vaxcyte in May were already two months behind a trade Baupost had quietly begun unwinding. Understanding exactly what got lost in that gap changes how ...